Nuclear Medicine: Page 389

Molecular Insight Pharmaceuticals to start phase III trials

By AuntMinnie.com staff writers

Radioisotope imaging developer Molecular Insight Pharmaceuticals will proceed with phase III trials of its molecular imaging pharmaceutical, (123I)-BMIPP, for the visualization of cardiac metabolism.

September 14, 2003

GE upgrades Millennium MyoSight

By AuntMinnie.com staff writers

GE Medical Systems debuted the second generation of its Millennium MyoSight gamma camera at this week’s American Society of Nuclear Cardiology meeting.

September 14, 2003

Siemens debuts c.cam

By AuntMinnie.com staff writers

Siemens Medical Solutions has introduced c.cam, a reclining dedicated cardiac gamma camera system.

September 11, 2003

ARRT adds nuclear medicine to CT registry

By AuntMinnie.com staff writers

The American Registry of Radiologic Technologists has expanded its certification in CT to include nuclear medicine technology as a supporting category.

September 11, 2003

Illuminating the mind: Imaging explores the mysteries of meditation

By Shalmali Pal

Ten million adults in the U.S. now practice some form of meditation in an effort to cope with the stresses of modern life. In turn, the mental health community is taking a closer look at the effects of meditation on the brain and its function, in a new specialty called neurotheology -- making a direct link between the neurosciences and spiritual experiences.

September 10, 2003

MDS records Q3 uptick in Life Sciences group

By AuntMinnie.com staff writers

MDS, the Toronto-based parent company of Canadian medical isotope supplier MDS Nordion, reported that its Life Sciences division, which includes MDS Nordion, had fiscal 2003 third-quarter revenues of $279 million, Canadian ($203.3 million, U.S.).

September 3, 2003